Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by
progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). It …

Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease.
Healthy tissue is replaced by altered extracellular matrix and alveolar architecture is …

Background: This document updates the American Thoracic Society/European Respiratory
Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on …

Pulmonary fibrosis is an irreversible and progressive disease affecting the lungs, and the
etiology remains poorly understood. This disease can be lethal and currently has no specific …

Rationale: Treatment options for idiopathic pulmonary fibrosis (IPF) are limited. Objectives:
To evaluate the efficacy and safety of BG00011, an anti-αvβ6 IgG1 monoclonal antibody, in …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible
lung disease characterized by pulmonary fibrosis and lung dysfunction, ultimately leading to …

Patient advocacy groups play an important role in supporting patients with chronic diseases
and promoting better care. The aim of this patient–physician initiative was to gather …

Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial
pneumonias. It is characterized by a chronic, progressive, fibrotic interstitial lung disease of …

Idiopathic pulmonary fibrosis (IPF) is a fibrotic interstitial lung disease associated with
significant morbidity and mortality. Previously, IPF has been managed using …

Along with increasing age and male sex, potential risk factors for IPF include cigarette
smoking, environmental exposures, microbial pathogens, and genetic factors. 1 Anyone with …